REDUCTION IN HEPATIC INFLAMMATION IS ASSOCIATED WITH LESS FIBROSIS PROGRESSION AND FEWER CLINICAL OUTCOMES IN ADVANCED HEPATITIS C

OBJECTIVE: During the Hepatitis C Antiviral Long-term Treatment against Cirrhosis Trial, 3.5 years of maintenance peginterferon-alfa-2a therapy did not affect liver fibrosis progression or clinical outcomes among 1,050 prior interferon nonresponders with advanced fibrosis or cirrhosis. We investigat...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Morishima, Chihiro, Shiffman, Mitchell L., Dienstag, Jules L., Lindsay, Karen L, Szabo, Gyongyi, Everson, Gregory T., Lok, Anna S., Di Bisceglie, Adrian M., Ghany, Marc G., Naishadham, Deepa, Morgan, Timothy R., Wright, Elizabeth C.
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3865099/
https://ncbi.nlm.nih.gov/pubmed/22688849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ajg.2012.137
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires